Precision Business Insights
Portfolio

 
Research Reports

Needle Free Drug Delivery Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Needle Free Drug Delivery Market

 

By Technology (Jet injectors, Inhaler Technology, Novel Needle Free Technologies, and Transdermal Patch Technology), By Site of Delivery (Intra Dermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors), By Applications (Pain Management, Insulin Delivery, Vaccine Delivery, and Others), By Distribution Channel (Hospitals, Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global needle free drug delivery market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Needle Free Drug Delivery Market

Needle free drug delivery devices are the medical devices that deliver the drug through the skin using the forces such as shock waves, pressurized gas or electrophoresis and by Lorentz which propels the drug through the skin which virtually nullify the use of the hypodermic needles. Large number of the patients opting for self-administration of drugs which would be possible using the needle free drug delivery devices. The adoption of the needle free drug delivery devices helps in reducing the healthcare expenses to the patients.

 

Increase in the prevalence of chronic diseases such as hepatitis B, hepatitis C, AIDS etc. which drives the extensive use of injections and in turn helps in the needle free drug delivery market revenue growth. The growing necessity of self-administration and a significant growth of the geriatric population adding fuel for the growth of the needle free drug delivery market. The ease of administration and pain-free drug delivery and increasing focus on the portable delivery devices has boosted the market growth. However, the restricted use of the needle-free injection systems may hamper the growth of the needle free drug delivery market.

 

Market Scope: Needle Free Drug Delivery Market

Needle free drug delivery market is segmented based on the technology, site of delivery, applications, and distribution channel

Based on the technology, the market is segmented into the following:

  • Jet Injectors
  • Inhaler Technology
  • Novel Needle Free Technologies
  • Transdermal Patch Technology

Based on the site of delivery, the market is segmented into the following:

  • Intradermal Injectors
  • Intramuscular Injectors
  • Subcutaneous Injectors

Based on the applications, the market is segmented into the following:

  • Pain Management
  • Insulin Delivery
  • Vaccine Delivery
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Others

 

Geographically, global needle free drug delivery market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America needle free drug delivery market is accounted for significant owing to increase in the prevalence of chronic disorders. The adoption of the modern treatments is anticipated to drive the growth of the free drug delivery market. The Asia Pacific is expected to grow faster rate over the forecast period owing to the growing prevalence of chronic diseases and favorable patient demographics.

 

Competition Assessment: Needle Free Drug Delivery Market

Some of the players in the global needle free drug delivery market include:

  • Inovio Pharmaceuticals, Inc.(U.S)
  • 3M Pharmaceuticals (U.S)
  • Antares Pharma, Inc. (U.S)
  • Crossject SA (France)
  • Becton Dickinson and Company (U.S)
  • MedImmune, Inc. (U.S)
  • Optinose, Inc. (U.S)
  • PharmaJet (U.S)

 

Notable Market Developments: Needle Free Drug Delivery Market

  • In February 2017, PharmaJet and Genexine collaborate on DNA vaccine development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Inovio Pharmaceuticals, Inc.(U.S)
  • 3M Pharmaceuticals (U.S)
  • Antares Pharma, Inc. (U.S)
  • Crossject SA (France)
  • Becton Dickinson and Company (U.S)
  • MedImmune, Inc. (U.S)
  • Optinose, Inc. (U.S)
  • PharmaJet (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements